Viewing Study NCT00083759


Ignite Creation Date: 2025-12-24 @ 3:02 PM
Ignite Modification Date: 2026-03-09 @ 8:49 PM
Study NCT ID: NCT00083759
Status: TERMINATED
Last Update Posted: 2016-07-18
First Post: 2004-06-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Natalizumab in the Treatment of Rheumatoid Arthritis in Subjects Receiving Methotrexate
Sponsor: Biogen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Baseline Characteristics Module Participant Flow Module